What Happened
A federal grand jury in Kansas City, Kansas, indicted pharmacist Benjamin Dandurand, 34, of Shawnee Mission, in February 2022 on one count of tampering with a consumer product and three counts of possession of controlled substances by deception and subterfuge: tramadol, zolpidem and oxycodone hydrochloride. He allegedly used his fingerprint to open a safe at a pharmacy in Lenexa and, from July to October 2020, removed oxycodone and replaced it with an alternate liquid. He also allegedly took tramadol, oxycodone and zolpidem between September and October 2020. An indictment is merely an allegation.
“returned an indictment charging a pharmacist with one count of tampering with a consumer product”
Related Guidance
- 15 Red Flags of Drug Diversion — Behavioral and transactional indicators of diversion.
- Investigation Playbook — How to investigate suspected diversion inside an organization.